Meningococcal Disease: Vaccines–Who’s at Risk and the Future
Registration Deadline: February 29, 2020
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Lippincott Professional Development will award 1.5 contact hours for this continuing nursing education activity. This activity has been assigned 1.0 pharmacology credits.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia and Florida, CE Broker #50-1223. Your certificate is valid in all states.